Table of Contents

company-logo

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.

NextCure Dividend Announcement

• NextCure does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on NextCure dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

NextCure Dividend History

NextCure Dividend Yield

NextCure current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing NextCure stock? Use our calculator to estimate your expected dividend yield:

NextCure Financial Ratios

P/E ratio-0.65
PEG ratio-0.01
P/B ratio0.50
ROE-62.50%
Payout ratio0.00%
Current ratio9.07
Quick ratio9.07
Cash Ratio3.19

NextCure Dividend FAQ

Does NextCure stock pay dividends?
NextCure does not currently pay dividends to its shareholders.
Has NextCure ever paid a dividend?
No, NextCure has no a history of paying dividends to its shareholders. NextCure is not known for its dividend payments.
Why doesn't NextCure pay dividends?
There are several potential reasons why NextCure would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will NextCure ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While NextCure has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is NextCure a dividend aristocrat?
NextCure is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is NextCure a dividend king?
NextCure is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is NextCure a dividend stock?
No, NextCure is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy NextCure stocks?
To buy NextCure you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy NextCure stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.